ACM
AKYA

Altium Capital Management’s Akoya BioSciences AKYA Stock Holding History

Altium Capital Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500,000
Closed -$4.09M – 69
2023
Q1 		$4.09M Buy
500,000
+170,000
+52% +$1.78M 2.27% 15
2022
Q4 		$3.16M Buy
330,000
+34,000
+11% +$418K 1.6% 22
2022
Q3 		$3.48M Hold
296,000
– – 1.28% 32
2022
Q2 		$3.8M Buy
+296,000
New +$3.07M 1.52% 22

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Altium Capital Management's AKYA Position: Q2 2023 in Review

Altium Capital Management sold out of Akoya BioSciences (AKYA) in Q2 2023, closing a stake of 500,000 shares — an estimated $4.09M sold.

Altium Capital Management first reported a position in AKYA in Q2 2022 and held it in 4 quarters. The position peaked at $4.09M in Q1 2023. 73 funds tracked by Wall St. Rank hold AKYA as of Q2 2023.

  • Altium Capital Management reported no remaining Akoya BioSciences position as of Q2 2023 after selling out during the quarter.
  • Altium Capital Management sold 500,000 Akoya BioSciences shares in Q2 2023, an estimated $4.09M.
  • Altium Capital Management first reported a position in Akoya BioSciences in Q2 2022 and held it in 4 quarters.
  • Altium Capital Management's Akoya BioSciences position peaked at $4.09M in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2023.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.